Category Archives: Uncategorized

“Ending AIDS” will mean filling cracks and chasms of neglect, inequity and exclusion . . . We’re reading about HLM 2016 AIDS

By on .

The United Nations High-Level Meeting on Ending AIDS this week could give the impression by its name alone that, but for a few loose ends, the end of HIV as a global health threat is within grasp. But in numbers alone, with fewer than half the people living with HIV worldwide accessing the antiretroviral treatment […]

Risk rate of Zika infection during pregnancy leading to microcephaly pegged as high as 13 percent, while legislators hold a hearing and funding remains on hold

By on .

Examining data from a succession of settings that have seen Zika outbreaks followed by rising rates of microcephaly among babies born to women infected with the virus during pregnancy, Harvard researchers now say risks of maternal infection leading to the birth defect ranges from 1- to 13 percent. Based on data from Brazil and French […]

With biomedical research driven by profit rather than need, MSF examines why innovation fails to address world’s biggest health problems

By on .

Report proposes new and focused approaches to developing drugs, diagnostics and vaccines A pharmaceutical company develops a long-awaited drug that represents the last hope for hundreds of thousands of people sick with drug-resistant tuberculosis, but doesn’t register it in any of the countries where the burden of the disease is greatest. While the World Health […]

Scientists find way to identify people at risk for active tuberculosis disease

By on .

An international team of researchers have found a way to determine which individuals infected with tuberculosis are most likely to develop active TB disease in the future. This important discovery, made with support from the National Institutes of Health, would allow doctors to identify people who are at high risk of developing active tuberculosis disease and […]

With TB now No. 1 global infectious disease killer, USAID justifies cuts to global TB funding

By on .

When House Appropriations Committee members in 2014 asked then USAID Administrator Raj Shah how the U.S. could combat tuberculosis globally with 19 percent less money, he said not to worry. The Global Fund to Fight AIDS, TB and Malaria, and the President’s Emergency Plan for AIDS Relief would fill the gap, he said. Two years […]

Data mapping highlights realities of global hepatitis C impacts, resources

By on .

Across 18 countries the price for a complete package of diagnostic tests for hepatitis C ranges from $67 to nearly ten times that amount, with many of the highest prices in the poorest countries. Of 23 countries contributing information on hepatitis C treatment access, only eight have access to new, safer, more effective treatments. Among […]

White House slashes TB funding less than two months after launching National Plan to Combat MDR-TB

By on .

The State Department’s funding document released following the White House budget today shows the Administration proposed the same amount for tuberculosis programs this year as it did last year — even after releasing an ambitious plan to reach more people worldwide with treatment for drug resistant TB. The State Department’s budget justification proposes a $45 million cut to […]

PEPFAR releases technical considerations for country, regional HIV responses

By on .

With a focus on both scaled up goals and limited funding, PEPFAR released its Technical Considerations for COP/ROP 2016 this week, outlining strategies necessary to provide access to testing and effective treatment to more people immediately, while maintaining efforts to confront tuberculosis and deliver other essential prevention and health services. Changes to the document reflect […]